Jacobs Levy Equity Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,776	Closed	-$1.81M	–	930
2019 Q2	$1.81M	Sell	12,776 -100	-0.8%	-$13.6K	0.03%	542
2019 Q1	$1.87M	Sell	12,876 -49,766	-79%	-$6.54M	0.03%	519
2018 Q4	$7.09M	Sell	62,642 -110	-0.2%	-$13.8K	0.12%	186
2018 Q3	$8.44M	Buy	62,752 +41,922	+201%	+$5.17M	0.12%	202
2018 Q2	$2.34M	Buy	20,830 +16,930	+434%	+$1.83M	0.04%	474
2018 Q1	$416K	Buy	+3,900	New	+$420K	0.01%	807
2017 Q2	–	Sell	-8,610	Closed	-$774K	–	945
2017 Q1	$774K	Sell	8,610 -33,660	-80%	-$2.86M	0.02%	597
2016 Q4	$3.22M	Buy	42,270 +90	+0.2%	+$6.83K	0.06%	324
2016 Q3	$3.52M	Sell	42,180 -45,830	-52%	-$3.84M	0.06%	321
2016 Q2	$7.26M	Sell	88,010 -32,470	-27%	-$2.67M	0.15%	191
2016 Q1	$9.15M	Sell	120,480 -19,830	-14%	-$1.47M	0.19%	155
2015 Q4	$11.3M	Sell	140,310 -15,400	-10%	-$1.11M	0.22%	137
2015 Q3	$9.89M	Buy	155,710 +44,060	+39%	+$3.16M	0.2%	147
2015 Q2	$7.85M	Buy	111,650 +43,110	+63%	+$3.19M	0.15%	175
2015 Q1	$5.43M	Buy	+68,540	New	+$5.06M	0.09%	220
2014 Q4	–	Sell	-6,000	Closed	-$358K	–	837
2014 Q3	$358K	Sell	6,000 -11,820	-66%	-$676K	0.01%	644
2014 Q2	$954K	Sell	17,820 -9,650	-35%	-$530K	0.02%	521
2014 Q1	$1.66M	Buy	+27,470	New	+$1.6M	0.03%	432